Exact Sciences Corp (EXAS) reports a 13% revenue increase and record free cash flow, while navigating disruptions and ...

At this time, I would like to welcome everyone to the Exact Sciences third-quarter 2024 earnings conference call. [Operator ...

At this time, I would like to welcome everyone to the Exact Sciences Third Quarter 2024 Earnings ... the normal 30-day timing between a Cologuard order and a completed test. Second, disruption ...

Exact Sciences' Q3 earnings report has led to a ... quarter revenue due to the normal 30-day timing between a Cologuard order and a completed test", and also pointed to the fact that "disruption ...

Exact Sciences stock collapsed Wednesday after the Cologuard maker reported light third-quarter sales and cut its full-year ...

Warning! GuruFocus has detected 5 Warning Sign with EXAS. Exact Sciences Corporation (NASDAQ:EXAS), a leader in cancer screening and diagnostic tests, has recently filed its 10-Q report on November 5, ...

Exact Sciences EXAS is slated to report its third ... digital reminders and educating providers about the option to order Cologuard in advance of a patient's three-year Cologuard anniversary.

Castle Biosciences held a groundbreaking ceremony for its new building at 1500 W. Parkwood Ave. on Oct. 22. The HBJ ...

While these illnesses may initially present with similar symptoms, a study from the University of Southern California has pinpointed the exact sequence ... specific symptom order to get tested ...